With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Related Articles
Leave a Reply
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Get the latest trends and breaking news delivered to your inbox daily. No spam, just the good stuff.
Our content is free because of ads. Please support New Trend by disabling your ad blocker.
